Advanced Filters
noise

polycystic-ovarian-syndrome Clinical Trials

A listing of polycystic-ovarian-syndrome medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 99 clinical trials
K Katherine Ann R Miller, Undergraduate medical student

LETROZOLE EXTENDED VS TRADITIONAL THERAPY FOR OVULATION INDUCTION IN WOMEN WITH PCOS: A RANDOMIZED CONTROLLED TRIAL

This randomized clinical trial aims to compare the efficacy and safety of extended letrozole therapy (5 mg/day for 10 days) versus standard letrozole therapy (5 mg/day for 5 days) for ovulation induction in women with polycystic ovary syndrome (PCOS). A total of 84 women aged 18-40 years will be randomized …

18 - 40 years of age Female Phase N/A
A Ali Ismail, lecturer

PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes

Women with polycystic ovarian syndrome (PCOS) may complain dryness of their eyes especially obese ones. lifestye changes are main treatrment fro both problems

30 - 40 years of age Female Phase N/A
R Rehana Rehman, PhD

Vitamin D and Polycystic Ovarian Syndrome (PCOS)

Primary Objectives: To evaluate the efficacy of metformin and Vitamin D supplementation on serum insulin and serum androgen levels (Total testosterone, Steroid Hormone Binding Globulin, Free Androgen Index) levels compared metformin alone in infertile Poly cystic ovarian females of reproductive age group. Secondary Objectives: To measure change in endometrial thickness/number …

18 - 36 years of age All Phase 2
R Rachel Study Coordinator

In Vitro Maturation of Human Eggs

CCRM Fertility, a global pioneer in fertility treatment, research and science, is seeking participants for a new study on in vitro maturation (IVM). IVM requires less hormones to stimulate the ovaries than IVF, making it more affordable than IVF with fewer side effects. Participants that qualify for the study will …

- 38 years of age Female Phase N/A
M Monika A Sarkar, MD

Bicalutamide Therapy in Young Women With NAFLD and PCOS

Nonalcoholic steatohepatitis (NASH), or fat-related liver inflammation and scarring is projected to be the leading cause of cirrhosis in the United States (U.S.) within the next few years. Women are at disproportionate risk for NASH, with approximately 15 million U.S. women affected. There is an urgent need to understand risk …

18 - 40 years of age Female Phase 1
A Ali Ismail, lecturer

Lifestyle Changes in PCOS with OSA and NAFLD

Complain of obstructive sleeping apnea and fatty liver is common in PCOS women so lifestyle changes are recommended

30 - 40 years of age Female Phase N/A
D Dr. Frank Hoentjen, MD

Fish Oil, Metformin and Heart Health in PCOS

Women with Polycystic Ovary Syndrome (PCOS) have high testosterone levels which is associated with altered insulin-glucose metabolism and an adverse blood lipid profile, predisposing them to the development of Type II Diabetes and Cardiovascular Disease (CVD). This study will investigate the use of dietary fish oil supplementation as a safe …

25 - 45 years of age Female Phase 1
I Inaam Arif, PhD

Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome

This study will investigate whether the addition of Quercetin or Alpha-Lipoic Acid (ALA) to standard metformin therapy can improve symptoms, hormone levels, metabolic health, and quality of life in women with polycystic ovary syndrome (PCOS). Over 3 months, participants will be randomly assigned to one of three groups: metformin alone, …

18 years of age All Phase 2
M Małgorzata M Wójcik, Dr

Use of TDCS Stimulation in Neurological and Gynaecological Conditions

The aim of the study is to test the effect of tDCS stimulation on upper and lower limb function in neurological patients and to reduce pain in gynaecological patients. And the impact of tDCS stimulation on patients' quality of life. Standardised questionnaires will be used for pre- and post-stimulation evaluation.

18 - 90 years of age All Phase N/A
A Alla Vash-Margita, Principal Investigator, MD

Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)

This study is a double blind, placebo controlled, randomized trial of study subjects with PCOS and low vitamin D to 2 groups- placebo and vitamin D replacement. Participants and investigators will be blinded to treatment modality until the end of the trial period

13 - 21 years of age Female Phase N/A

Simplify language using AI